Beautiful With Brains - Ingredients

JANUARY 5, 2024

If I had my way, I’d put zinc oxide in every sunscreen. I know, I know, it sometimes leaves an annoying white cast behind. And it can be a tad too greasy. I can put up with these little annoyances (of course, it helps my skin’s pale and dry). Nothing’s perfect. But zinc oxide comes […] The post Why Zinc Oxide Is The Best Sunscreen Ingredient Ever appeared first on Beautiful With Brains.

Ingredients 98

Ingredients Sun Protection 98

Skin Inc

JANUARY 5, 2024

how does a bill become a law, spa regulations, spa regulatory updates, regulation updates in the spa

Esthetician 98

Esthetician 98

Dermatology Times

JANUARY 5, 2024

Raj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, review clinical trial data for tapinarof cream, 1% in the treatment of AD.

Clinic 85

Clinic Treatments 85

Skin Inc

JANUARY 5, 2024

The esthetics pro sat down with Skin Inc. to discuss a brow trend that is always in style and why having a mentor is vital for any solo esthetician or business owner.

Esthetics 52

Esthetics Esthetician Customer Service 52

Dermatology Times

JANUARY 5, 2024

The approval marks a milestone for patients ages 6 months and older who face the persistent, highly contagious condition.

Treatments 74

Treatments 74

Skin Inc

JANUARY 5, 2024

winter skin tips, hydrating skin tips, dry skin tips, skin care tips, skin care education, compromised winter skin, skin exfoliation methods, body treatment tips

Dry Skin 52

Dry Skin Exfoliation Hydration Education 52

Alison Bladh

JANUARY 5, 2024

As midlife women navigate the changes their bodies undergo, adjusting dietary habits can play a crucial role in maintaining health and wellbeing. One significant change to consider is reducing the intake of carbohydrates, especially those derived from 'white' foods such as white bread, pasta, and sugar. These types of carbs can lead to spikes in blood sugar levels and may contribute to weight gain, a common concern during the menopausal years.

Management 52

Management Diet Ingredients 52

Dermatology Times

JANUARY 5, 2024

The filing is supported by positive phase 3 clinical trial data.

Rosacea 73

Rosacea Clinic 73

First Derm

JANUARY 5, 2024

Online Dermatologist White Bumps on the Face: Milia and Other Common Reasons Milia (Milk Spots) | Clogged Pores | Sebaceous Hyperplasia | Sebaceous Cysts Discover the causes and characteristics of white facial bumps, from milia to sebaceous cysts, in this concise guide to common skin conditions. White bumps on the face are a common occurrence, with causes ranging from sun exposure and aging to genetics and skin type.

Pores 40

Pores Sebum Comedogenic Exfoliation 40

Dermatology Times

JANUARY 5, 2024

The pilot study explored the use of double-conjugated retinoid serum used in combination with exfoliating peel pads.

Exfoliation 73

Exfoliation 73

The Dermatology Digest

JANUARY 5, 2024

The U.S. Food and Drug Administration (FDA) has approved Zelsuvmi (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum in adults and children one year of age and older. Zelsuvmi is expected to be commercially available during the second half of 2024, according to Ligand Pharmaceuticals. Zelsuvmi is the first novel drug for the treatment of molluscum infections and the first and only topical prescription medication that can be applied by patients, parents, or caregivers at h

Pharmaceutical 36

Pharmaceutical Office Medical Dermatology 36

Dermatology Times

JANUARY 5, 2024

In this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.

Treatments 73

Treatments 73

The Dermatology Digest

JANUARY 5, 2024

Journey Medical Corporation has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the treatment of inflammatory lesions and erythema of rosacea in adults. DFD-29 is being developed in collaboration with Dr. Reddy’s Laboratories Ltd.

Rosacea 36

Rosacea Medical Office Safety 36

Dermatology Times

JANUARY 5, 2024

Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.

68

68

The Dermatology Digest

JANUARY 5, 2024

The last patient has been dosed in Part 2 of Verrica Pharmaceuticals Inc.’s Phase 2 trial of VP-315, a potential first-in-class oncolytic peptide, for the treatment of basal cell carcinoma. VP-315 is a chemotherapeutic administered intratumorally. It works by inducing lysis of intracellular organelles of tumor cells such as mitochondria, thereby unleashing a broad spectrum of tumor antigens for T cell responses, the Company explains.

Pharmaceutical 36

Pharmaceutical Safety Office Clinic 36

Dermatology Times

JANUARY 5, 2024

The last patient has been dosed in the trial of the potential first-in-class oncolytic peptide for BCC.

36

36

Dermatology Times

JANUARY 5, 2024

Expert dermatologists discuss the use of nonsteroidal treatment formulations for the treatment of AD, focusing on a topical treatment, tapinarof cream, 1%.

Treatments 36

Treatments 36